SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001400482-15-000028
Filing Date
2015-03-26
Accepted
2015-03-25 19:00:59
Documents
6
Period of Report
2015-03-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acucela-q42014kt8k.htm 8-K 39948
2 EXHIBIT 10.01 blockerletteragreement.htm EX-10.01 11266
3 EXHIBIT 99.1 acucelaq42014ktrevision.htm EX-99.1 54985
4 EXHIBIT 99.2 acucela2014q4kt.htm EX-99.2 1038619
5 acucelalogoa03.gif GRAPHIC 7792
6 LOGO finaldocs3635043v1blo_image1.gif GRAPHIC 32162
  Complete submission text file 0001400482-15-000028.txt   1201557
Mailing Address 1301 SECOND AVE. SUITE 4200 SEATTLE WA 98101
Business Address 1301 SECOND AVE. SUITE 4200 SEATTLE WA 98101 206-805-8300
ACUCELA INC. (Filer) CIK: 0001400482 (see all company filings)

IRS No.: 020592619 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55133 | Film No.: 15725853
SIC: 2834 Pharmaceutical Preparations